{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:59Z","timestamp":1761058319415},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,2,1]],"date-time":"1986-02-01T00:00:00Z","timestamp":507600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutisch Weekblad Scientific Edition"],"published-print":{"date-parts":[[1986,2]]},"DOI":"10.1007\/bf01975481","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T12:56:30Z","timestamp":1123073790000},"page":"53-59","source":"Crossref","is-referenced-by-count":25,"title":["The quinolones in chronic bronchitis"],"prefix":"10.1007","volume":"8","author":[{"given":"B. I.","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. P. V.","family":"Maesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Teengs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01975481_CR1","first-page":"132","volume-title":"A clinical approach to progress in infectious diseases","author":"BI Davies","year":"1983","unstructured":"Davies BI, Maesen FPV. The diagnosis and treatment of respiratory infections. In: Brumfitt W, Hamilton-Miller JMT, eds. A clinical approach to progress in infectious diseases. Oxford: Oxford University Press, 1983:132\u201358."},{"key":"BF01975481_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02001575","volume":"2","author":"A Bauernfeind","year":"1983","unstructured":"Bauernfeind A, Peterm\u00fcller C.In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur J Clin Microbiol 1983;2:111\u20135.","journal-title":"Eur J Clin Microbiol"},{"key":"BF01975481_CR3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/AAC.24.2.302","volume":"24","author":"H Muytjens","year":"1983","unstructured":"Muytjens H, Van der Ros-van de Repe J, Van Veldhuizen G. Comparative activities of ciprofloxacin (Bay 09867), norfloxacin, pipemidic acid, and nalidixic acid. Antimicrob Agents Chemother 1983;24:302\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01975481_CR4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/AAC.25.6.775","volume":"25","author":"AL Barry","year":"1984","unstructured":"Barry AL, Jones RN. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin and oxolinic acid afterin vitro selection of resistant populations. Antimicrob Agents Chemother 1984;25:775\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01975481_CR5","first-page":"1","volume":"1","author":"R Wise","year":"1985","unstructured":"Wise R. The activity of quinolones against respiratory tract pathogenes. Quinolones Bull June 1985;1:1\u20132.","journal-title":"Quinolones Bull June"},{"issue":"suppl 0","key":"BF01975481_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/14.suppl_C.83","volume":"14","author":"BI Davies","year":"1984","unstructured":"Davies BI, Maesen FPV, Teengs JP. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study. J Antimicrob Chemother 1984;14(suppl 0):83\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"BF01975481_CR7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jac\/16.3.379","volume":"16","author":"FPV Maesen","year":"1985","unstructured":"Maesen FPV, Davies BI, Teengs JP. Pefloxacin in acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1985;16:379\u201388.","journal-title":"J Antimicrob Chemother"},{"key":"BF01975481_CR8","volume-title":"abstract S 50-3","author":"BI Davies","year":"1985","unstructured":"Davies BI, Maesen FPV, Baur C, Teengs JP, Cremer HMHG. Ciprofloxacin in purulent exacerbations of chronic bronchitis: a clinical microbiological and pharmacokinetic study. 14th International Congress of Chemotherapy. Kyoto. June 23\u201328. 1985. Kyoto: International Society of Chemotherapy, 1985:abstract S 50-3."},{"key":"BF01975481_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.0954-6820.1952.tb14249.x","volume":"143","author":"J Mulder","year":"1952","unstructured":"Mulder J, Goslings WRO, Van der Plas MC, Lopez Cardozo P. Studies on the treatment with antibacterial drugs of acute and chronic bronchitis caused byHaemophilus influenzae. Acta Med Scand 1952;143:32\u201349.","journal-title":"Acta Med Scand"},{"key":"BF01975481_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/9.2.149","volume":"9","author":"BI Davies","year":"1982","unstructured":"Davies BI, Maesen FPV; Brouwers J. Cefoperazone in acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1982;9:149\u201355.","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 5","key":"BF01975481_CR11","doi-asserted-by":"crossref","first-page":"S465","DOI":"10.1007\/BF01659773","volume":"7","author":"BI Davies","year":"1979","unstructured":"Davies BI, Maesen FPV. Serum and sputum antibiotic levels after ampicillin. amoxycillin and bacampicillin in chronic bronchitis patients. Infection 1979;7(suppl 5):S465\u20138.","journal-title":"Infection"},{"key":"BF01975481_CR12","first-page":"249","volume":"59","author":"BI Davies","year":"1978","unstructured":"Davies BI, Maesen FPV, Brombacher PJ, Sj\u00f6vall J. Twice daily dosage of bacampicillin in chronic bronchitis: a double blind study. Scand J Respir Dis 1978;59:249\u201356.","journal-title":"Scand J Respir Dis"},{"key":"BF01975481_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(84)90283-6","volume":"2","author":"WJA Wijnands","year":"1984","unstructured":"Wijnands WJA, Van Herwaarden CLA, Vree TB. Enoxacin raises plasma theophylline concentrations. Lancet 1984;2:108.","journal-title":"Lancet"},{"key":"BF01975481_CR14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(84)92617-5","volume":"2","author":"FPV Maesen","year":"1984","unstructured":"Maesen FPV, Teengs JP, Baur C, Davies BI. Quinolones and raised plasma concentrations of theophylline. Lancet 1984;2:530.","journal-title":"Lancet"}],"container-title":["Pharmaceutisch Weekblad Scientific Edition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01975481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01975481\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01975481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T18:30:58Z","timestamp":1557772258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01975481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,2]]}},"alternative-id":["BF01975481"],"URL":"https:\/\/doi.org\/10.1007\/bf01975481","relation":{},"ISSN":["0167-6555","1573-739X"],"issn-type":[{"value":"0167-6555","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,2]]}}}